- January 1 – OCAN Issue Brief on Department of Labor FAQ regarding coverage exclusions for weight management services – highlighting how non-grandfathered group health plans cannot contain general exclusions for weight management services for adult obesity. Additionally, the Department of Labor included examples of both specificity and intensity of multi component behavioral interventions for obesity. To view the full comment, CLICK HERE.
- January 13 – OCAN comments regarding the USPSTF draft research plan on behavioral and pharmacotherapy interventions for weight loss to prevent obesity-related morbidity and mortality in adults where OCAN urges the USPSTF to shift the direction of its research approach toward obesity care and follow a chronic disease management paradigm instead of an exclusive focus on weight loss. To view the full comment, CLICK HERE.
- January 26 – OCAN Comments on the Senate Finance Committee (SFC) Chronic Care Working Group (CCWG) options paper, where OCAN evaluated a number of policy proposals and how they could be adapted to encompass obesity treatment. Primarily though, OCAN highlighted how CMS’s failure to recognize obesity as a chronic disease state is severely hampering efforts to secure nationwide coverage for evidence-based obesity treatment options. OCAN laid out how obesity clearly meets CMS’s criteria for chronic care management payments, including that (1) obesity is highly prevalent among the Medicare population; (2) obesity is chronic; i.e., typically lasts for more than 12 months; (3) obesity poses increased risk for death, acute exacerbation/decompensation, or functional decline; (4) obesity results in increased use of health care services; and (5) successful care management of obesity can improve outcomes/reduce costs. To view the full comment, CLICK HERE.
- March 1 – OCAN comments regarding CMS Draft Quality Measure Development Plan to support new merit based incentive and alternative payment systems. In the comments, OCAN highlighted how there are very few quality measures established to drive optimal outcomes for people with obesity and evaluated what current measures do exist surrounding obesity and how they are being used, as well as the main opportunities for adaptation. To view the full comment, CLICK HERE.
- October 6 – OCAN comments in response to the proposed regulations entitled, “Patient Protection and Affordable Care Act (ACA); HHS Notice of Benefit and Payment Parameters for 2018.” To view the full comment, CLICK HERE.
- November 2 – The Obesity Care Advocacy Network (OCAN) urges the Healthcare Quality Expert Committee to include obesity agents under both the current U.S. Pharmacopeial Convention (USP) Medicare Model Guidelines (MMG) and the newly proposed USP Drug Classification system (USP DC). To view the full comment, CLICK HERE.
- December 5 – The Obesity Care Advocacy Network (OCAN) applauds the Healthcare Quality Expert Committee for including a
new class for obesity agents in the newly proposed USP Drug Classification system (USP DC) for 2017. To view the full comment, CLICK HERE.